17.09.2020 – 09:00 Debiopharm International SADEBIOPHARM TO PRESENT LATE BREAKING HEAD & NECK CANCER ABSTRACT AT THE 2020 EUROPEAN SOCIETY OF MEDICAL ONCOLOGY CONGRESS Lausanne, Switzerland (ots) - Debiopharm announces the presentation of the 3-year phase II follow-up data along with 2 posters for xevinapant (antagonist of IAP -Inhibitor of Apoptosis Proteins) and WEE1 inhibitor Debio 0123 Debiopharm, ... One documentmore
24.06.2020 – 09:03 Aurubis AG Press Release: Aurubis AG successfully places ESG-linked Schuldschein loan of EUR 400 million One documentmore
01.04.2019 – 16:50 Lamilux Heinrich Strunz GmbH 2TÜV Süd seal for LAMILUX Composites renewed One documentmore